Indication
Precocious puberty
Precocious puberty is an endocrine disorder characterized by the abnormally early onset of secondary sexual characteristics, defined clinically as physical signs of pubertal maturation appearing before age 8 in girls and before age 9 in boys. Read more about Precocious puberty
23 drugs 20 manufacturers
Drugs that treat it
Common Precocious puberty therapies.
SYNAREL (nafarelin acetate)
TRIPTODUR (triptorelin pamoate)
FENSOLVI (leuprolide acetate)
LUPRON DEPOT-PED (3 MONTH) (leuprolide acetate)
TRIPTODUR (triptorelin pamoate)
FENSOLVI (leuprolide acetate)
LEUPROLIDE ACETATE
TRIPTODUR (triptorelin pamoate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrecocious puberty is an endocrine disorder characterized by the abnormally early onset of secondary sexual characteristics, defined clinically as physical signs of pubertal maturation appearing before age 8 in girls and before age 9 in boys.
Pathophysiologically, it affects the pediatric endocrine and reproductive systems and is broadly categorized into central precocious puberty, caused by early premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty, driven by autonomous sex steroid secretion independent of central gonadotropins.
Clinical hallmarks include accelerated linear somatic growth, advanced skeletal maturation leading to premature epiphyseal fusion and compromised adult height, and phenotypic manifestations such as breast development, testicular enlargement, or pubic hair emergence.
- nih.gov
Precocious puberty is an endocrine disorder characterized by the abnormally early onset of secondary sexual characteristics, defined clinically as physical signs of pubertal maturation appearing before age 8 in girls and before age 9 in boys Clinical hallmarks include accelerated linear somatic growth, advanced skeletal maturation leading to premature epiphyseal fusion and compromised adult height, and phenotypic manifestations such as breast development, testicular enlargement, or pubic hair em...
- nih.gov
Precocious puberty is an endocrine disorder characterized by the abnormally early onset of secondary sexual characteristics, defined clinically as physical signs of pubertal maturation appearing before age 8 in girls and before age 9 in boys Clinical hallmarks include accelerated linear somatic growth, advanced skeletal maturation leading to premature epiphyseal fusion and compromised adult height, and phenotypic manifestations such as breast development, testicular enlargement, or pubic hair em...
- nih.gov
Pathophysiologically, it affects the pediatric endocrine and reproductive systems and is broadly categorized into central precocious puberty, caused by early premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty, driven by autonomous sex steroid secretion independent of central gonadotropins Clinical hallmarks include accelerated linear somatic growth, advanced skeletal maturation leading to premature epiphyseal fusion and compromised adult height, an...
- nih.gov
Pathophysiologically, it affects the pediatric endocrine and reproductive systems and is broadly categorized into central precocious puberty, caused by early premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty, driven by autonomous sex steroid secretion independent of central gonadotropins
Personalize your experience
Follow Precocious puberty and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.